COR Cencora, Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.…
Industry Peers
Medical DistributionKey Statistics
About Cencora (NYSE: COR)
›
Cencora (NYSE: COR) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Distribution industry, part of the Healthcare sector.
The shares were at 341.25 USD on 19 November 2026, down 5.3% over 52 weeks. Its 52-week range is 244.82 USD to 377.54 USD: the price is 9.6% below the high and 39.4% above the low.
At a market capitalisation of 65.12B USD, it trades at 19.0 times trailing earnings and 15.7 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 23.2, a discount of 18% for COR. It pays a dividend yielding 0.76% (it pays out 17% of its earnings), against a median of 2.55% among the dividend payers in that peer group.
Cencora reports return on equity of 129.0%, an operating margin of 1.4% and revenue up 5.5% year over year.
Its debt exceeds its cash by 6.39B USD, a debt-to-equity ratio of 5.08. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 388.25 USD is 13.8% above the current price. The next earnings report is expected on 3 February 2027.